Home Cart Sign in  
Chemical Structure| 603-87-2 Chemical Structure| 603-87-2

Structure of 603-87-2

Chemical Structure| 603-87-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 603-87-2 ]

CAS No. :603-87-2
Formula : C6H6N2O3
M.W : 154.12
SMILES Code : NC1=C(O)C(=CC=C1)[N+]([O-])=O
MDL No. :MFCD02751769
InChI Key :AACMNEWXGKOJJK-UHFFFAOYSA-N
Pubchem ID :5127291

Safety of [ 603-87-2 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 603-87-2 ] Show Less

Physicochemical Properties

Num. heavy atoms 11
Num. arom. heavy atoms 6
Fraction Csp3 0.0
Num. rotatable bonds 1
Num. H-bond acceptors 3.0
Num. H-bond donors 2.0
Molar Refractivity 41.69
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

92.07 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.0
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

1.6
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.89
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.3
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.49
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.34

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.14
Solubility 1.11 mg/ml ; 0.00722 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-3.14
Solubility 0.11 mg/ml ; 0.000716 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.83
Solubility 22.8 mg/ml ; 0.148 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.1 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

4.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.99

Application In Synthesis of [ 603-87-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 603-87-2 ]
  • Downstream synthetic route of [ 603-87-2 ]

[ 603-87-2 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 573-56-8 ]
  • [ 603-87-2 ]
YieldReaction ConditionsOperation in experiment
95% With hydrogen In ethyl acetate for 5 h; To a nitrogen flushed solution of 2, 6-dinitrophenol (10 g, 54.3 mmol) in ethyl acetate (100 ml) was added 10percent palladium on carbon (0.5 g) and the resulting mixture stirred under a balloon of hydrogen for 5 hours. The catalyst was removed by filtration and the filtrate evaporated to give the title compound (8.0 g, 95percent). 1H NMR (400 MHz, CDC13) 8 3.95 (2H, br s), 6.78 (1H, t, J 8. 4 and 8.0), 6.95 (1H, dd, J7. 6 and 1.2), 7.46 (1H, DD, J 8. 6 AND 1.2).
92% With palladium 10% on activated carbon; hydrogen In methanol for 1 h; To a of solution of 2,6-dinitrophenol (5.43 mmol, 1.00 g) in methanol (100 mL), 10percent palladium on activated carbon (10 wtpercent of 2,6-dinitrophenol, 0.10 g) was added. The reaction was flushed with argon followed by hydrogen for fifteen minutes each with constant magnetic stirring. The reaction was then maintained under hydrogen atmosphere at ordinary pressure (balloon) for one hour. The reaction was monitored closely by thin layer chromatography to avoid over reduction.1 Argon was again flushed through the reaction vessel for 15 minutes. Then the reaction contents were filtered over a thin pad of celite which was then washed with methanol (50 mL). The filtrate was concentrated in vacuo yielding a brown solid. Silica gel column chromatography (10:1 hexanes/ethyl acetate) provided a crystalline red solid in a 92percent yield.
60%
Stage #1: With sodium sulfide; ammonia; ammonium chloride In water at 70℃; for 2 h;
Stage #2: With hydrogenchloride In water
2-Amino-6-nitrophenol: A suspension of 2,6-dinitrophenol 5.0 g (27 mmol), ammonium hydroxide (3 ml) and ammonium chloridel4. 3 g (270 mmol) in 30 ml of water was heated to 70°C. A solution of sodium sulfide nonahydrate (24.19 g, 100 mmol) in water was added and the resulting mixture stirred at 70°C for 2h. The reaction was cooled to room temperature, acidified (pH 3.2) with 2N HC1, and the brown precipitate separated by filtration. The filtrate was extracted with chloroform (6 x 75 ml), the organic extracts combined with the precipitate, and evaporated in-vacuo to yield 2.5 g (60 percent) of product as a dark brown solid. 1H NMR (CDC13) 5 4.09 (s, 2H), 6.78 (t, 1H, J = 8. 2 Hz), 6.95 (d, 1H, J = 7.8 Hz), 7.47 (d, 1H, J = 8.6 Hz), 10.73 (s, 3H).
48% With palladium 10% on activated carbon; hydrogen In ethyl acetate at 20℃; for 144 h; Step 1
2-Amino-6-nitrophenol
8.6 g of 2,6-dinitrophenol (46.71 mmol) were dissolved in 95 ml of ethyl acetate.
The solution was degassed and then 0.86 g (10percent by weight) of palladium on carbon at 10percent was added.
The reaction medium was stirred under a hydrogen atmosphere for 6 days at ambient temperature.
The reaction medium was filtered through celite and concentrated to dryness.
The residue obtained was chromatographed on a cartridge of silica gel eluted with 100percent dichloromethane to 80/20 dichloromethane/ethyl acetate.
3.43 g of product were obtained in the form of a dark copper solid. Yield=48percent.
2.41 g With palladium 10% on activated carbon; hydrogen In ethyl acetate for 5 h; (1)
A solution of 2,6-dinitrophenol (6.31 g, 27.4 mmol) in ethyl acetate (50 mL) was cooled to 0°C, 10percent palladium activated carbon (250 mg) was added thereto, and the mixture was stirred under a hydrogen atmosphere for 5 hr.
The reaction mixture was filtered through Celite (registered trademark) and the filtrate was concentrated under reduced pressure.
The resulting residue was diluted with chloroform, anhydrous sodium sulfate was added thereto, and the mixture was stirred for 15 min.
Anhydrous sodium sulfate was filtered off, followed by concentration under reduced pressure.
The resulting residue was powdered with hexane and collected by filtration to afford 2-amino-6-nitrophenol as a brown amorphous substance (2.41 g).

References: [1] Patent: WO2005/28445, 2005, A2, . Location in patent: Page/Page column 38.
[2] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 15, p. 3521 - 3525.
[3] Journal of Medicinal Chemistry, 2004, vol. 47, # 6, p. 1319 - 1321.
[4] Patent: WO2005/44793, 2005, A2, . Location in patent: Page/Page column 135.
[5] Patent: US2014/309208, 2014, A1, . Location in patent: Paragraph 0237; 0238.
[6] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 8, p. 2512 - 2515.
[7] Justus Liebigs Annalen der Chemie, 1880, vol. 205, p. 72.
[8] Chemische Berichte, 1959, vol. 92, p. 407,410.
[9] Patent: US5496853, 1996, A, .
[10] Patent: US2006/264631, 2006, A1, . Location in patent: Page/Page column 27; 39.
[11] Patent: EP2687507, 2014, A1, . Location in patent: Paragraph 0347.
  • 2
  • [ 95-55-6 ]
  • [ 603-87-2 ]
  • [ 99-57-0 ]
References: [1] Russian Journal of Organic Chemistry, 1997, vol. 33, # 3, p. 348 - 352.
  • 3
  • [ 74255-39-3 ]
  • [ 603-87-2 ]
References: [1] Journal of the Chemical Society, 1927, p. 1057.
  • 4
  • [ 614-80-2 ]
  • [ 603-87-2 ]
References: [1] Journal of the Chemical Society, 1927, p. 1057.
  • 5
  • [ 7664-93-9 ]
  • [ 860728-40-1 ]
  • [ 603-87-2 ]
References: [1] Chemische Berichte, 1914, vol. 47, p. 1007.
  • 6
  • [ 7664-93-9 ]
  • [ 861528-05-4 ]
  • [ 603-87-2 ]
References: [1] Chemische Berichte, 1914, vol. 47, p. 1007.
  • 7
  • [ 7647-01-0 ]
  • [ 860728-44-5 ]
  • [ 603-87-2 ]
References: [1] Journal of the Chemical Society, 1928, p. 3070.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 603-87-2 ]

Aryls

Chemical Structure| 601-89-8

A141918 [601-89-8]

2-Nitrobenzene-1,3-diol

Similarity: 0.93

Chemical Structure| 16600-92-3

A475053 [16600-92-3]

2-Nitrobenzene-1,3,5-triol

Similarity: 0.93

Chemical Structure| 704-14-3

A141862 [704-14-3]

5-Methoxy-2-nitrophenol

Similarity: 0.88

Chemical Structure| 577-72-0

A201413 [577-72-0]

4-Methoxy-3-nitroaniline

Similarity: 0.88

Chemical Structure| 15174-02-4

A404806 [15174-02-4]

4-Methoxy-3-nitrophenol

Similarity: 0.88

Amines

Chemical Structure| 577-72-0

A201413 [577-72-0]

4-Methoxy-3-nitroaniline

Similarity: 0.88

Chemical Structure| 139138-08-2

A217306 [139138-08-2]

2-Amino-4-bromo-6-nitrophenol

Similarity: 0.87

Chemical Structure| 17508-17-7

A934560 [17508-17-7]

O-(2,4-Dinitrophenyl)hydroxylamine

Similarity: 0.84

Chemical Structure| 67827-72-9

A183544 [67827-72-9]

2-Methoxy-5-nitroaniline hydrochloride

Similarity: 0.82

Chemical Structure| 16292-88-9

A218754 [16292-88-9]

3-Methoxy-4-nitroaniline

Similarity: 0.81

Nitroes

Chemical Structure| 601-89-8

A141918 [601-89-8]

2-Nitrobenzene-1,3-diol

Similarity: 0.93

Chemical Structure| 16600-92-3

A475053 [16600-92-3]

2-Nitrobenzene-1,3,5-triol

Similarity: 0.93

Chemical Structure| 704-14-3

A141862 [704-14-3]

5-Methoxy-2-nitrophenol

Similarity: 0.88

Chemical Structure| 577-72-0

A201413 [577-72-0]

4-Methoxy-3-nitroaniline

Similarity: 0.88

Chemical Structure| 15174-02-4

A404806 [15174-02-4]

4-Methoxy-3-nitrophenol

Similarity: 0.88